Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator

被引:3
|
作者
Hirano, T [1 ]
Mori, T [1 ]
Kido, M [1 ]
Toide, K [1 ]
Ohura, M [1 ]
Fujiki, H [1 ]
Orito, K [1 ]
Yoshida, K [1 ]
Ikezono, K [1 ]
Sumida, T [1 ]
Nakayama, N [1 ]
Yabuuchi, Y [1 ]
机构
[1] Otsuka Pharmaceut Co Ltd, Tokushima Inst New Drug Res 2, Tokushima 7710192, Japan
关键词
pranidipine; optical-isomers; calcium channel blocking action; isolated aorta; anaesthetized rat; structure-activity relationship; spontaneously hypertensive rats;
D O I
10.1111/j.1472-8206.1999.tb00376.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pranidipine is an optically-active 1,4-dihydropyridine (DHP) voltage-dependent L-type calcium channel inhibitor. Certain enantiomeric pairs display opposite effects, i.e., inhibition and activation of the calcium channel while others exhibit the same qualitative actions. We investigated pranidipine, a new DHP, using a paradigm of vascular smooth muscle reactivity. In isolated rat aorta, depolarized with 80 mM KCl, both isomers of pranidipine caused a right-ward shift of the concentration-contraction curves for extracellular Ca2+. The apparent pA(2) values of the S-isomer and R-isomer were 10.03 and 8.36, respectively, providing evidence that the calcium channel blocking action of the S-isomer was 50 times more potent than that of the R-isomer. Antihypertensive actions of these two isomers studied in pentobarbital-anaesthetized spontaneously hypertensive rats, revealed that the S-isomer, at doses of 3-30 mu g/kg i.v. decreased blood pressure in a dose-dependent manner, while the R-isomer had no effect on blood pressure at those doses. We conclude that the pair of enantiomers of pranidipine qualitatively display the same Ca2+ channel blocking action and that neither isomer exhibits Bay K 8644-like activation. Pranidipine may be useful in studies on the architecture of the DHP receptor 'pocket'. (C) 1999 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:650 / 655
页数:6
相关论文
共 50 条
  • [1] Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation
    Mori, T
    Takase, H
    Toide, K
    Hirano, T
    Kambe, T
    Nakayama, N
    Schwartz, A
    CARDIOVASCULAR DRUG REVIEWS, 2001, 19 (01): : 1 - 8
  • [2] Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects
    K. Hashimoto
    T. Shirafuji
    H. Sekino
    O. Matsuoka
    H. Sekino
    O. Onnagawa
    T. Okamoto
    S. Kudo
    J. Azuma
    European Journal of Clinical Pharmacology, 1998, 54 : 753 - 760
  • [3] Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects
    Hashimoto, K
    Shirafuji, T
    Sekino, H
    Matsuoka, O
    Sekino, H
    Onnagawa, O
    Okamoto, T
    Kudo, S
    Azuma, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (9-10) : 753 - 760
  • [4] Obtaining antibodies to 1,4-Dihydropyridine calcium channel antagonists
    A. A. Burkin
    M. A. Burkin
    Applied Biochemistry and Microbiology, 2008, 44 : 323 - 327
  • [5] QSAR STUDY ON 1,4-DIHYDROPYRIDINE AS CALCIUM CHANNEL ANTAGONISTS
    Singh, J.
    Shaik, B.
    Shukla, S. K.
    Sharma, M.
    Singh, S.
    Agrawal, V. K.
    OXIDATION COMMUNICATIONS, 2013, 36 (03): : 761 - 777
  • [6] Obtaining antibodies to 1,4-dihydropyridine calcium channel antagonists
    Burkin, A. A.
    Burkin, M. A.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2008, 44 (03) : 323 - 327
  • [7] QSAR Analysis of 1,4-Dihydropyridine Calcium Channel Antogonists
    Kahraman, Pinar
    Turkay, Metin
    17TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2007, 24 : 977 - 982
  • [8] Different pharmacological properties of the optical isomers of MN9202, a novel 1,4-dihydropyridine Ca2+channel modulator, in rat ventricular myocytes
    Li, Xiao-Qiang
    Cao, Wei
    Zeng, Ai-Guo
    Yang, Zhi-Fu
    Xing, Bin
    Dong, Ling
    Zhang, Hai-Feng
    Mei, Qi-Bing
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (08) : 817 - 825
  • [9] DIFFERENTIAL-EFFECTS OF 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS - THERAPEUTIC IMPLICATIONS
    KATZ, AM
    LEACH, NM
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (11): : 825 - 834
  • [10] MODULATION OF CALCIUM-CHANNEL FUNCTION WITH THE 1,4-DIHYDROPYRIDINE STRUCTURE
    SCHRAMM, M
    TOWART, R
    JOURNAL OF PHYSIOLOGY-LONDON, 1984, 349 (APR): : P53 - P53